RSV vaccine access expanded to some people in their 50s, according to CDC website The decision appears on a CDC webpage but wasn’t on the agency’s official adult immunization schedule.

The CDC published a new recommendation this week calling for some adults ages 50 to 59 to get vaccinated for respiratory syncytial virus (RSV).

RSV is the leading pathogen of lower respiratory tract infections (LRTIs) in infants and young children globally, causing approximately 33 million cases of LRTIs, 3.6 million hospitalizations, and ...

Among adults with outpatient respiratory syncytial virus (RSV) infections across six RSV seasons, roughly one in 20 were hospitalized within 28 days, according to a large cohort study that used ...

CDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV Shot — RFK Jr. also endorsed a new option for meningococcal vaccination ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the use of respiratory syncytial virus vaccines in adults aged between 50 and ...

This is the first time WHO has included an anti-RSV drug developed from China in the paediatric drug optimization priority list. Filling a Global Gap: Ziresovir Leads RSV Antiviral Development ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, months before they were abruptly fired by U.S. Health Secretary Robert ...

Fact checked by Nick Blackmer The Centers for Disease Control and Prevention (CDC) has expanded the RSV vaccine recommendation to include adults 50 and older who are at higher risk of severe ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.

The RSV vaccine is now recommended for adults aged 50 to 59 who are at a high risk of severe infection.